Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.
Related Articles
TRiCares Announces First Topaz Implantations in US Early Feasibility Study
Paris, France and Munich, Germany, January 09, 2025 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid valve that flexes…
Bilateral Basal Ganglia Region Infarction After Trauma in a Patient With Bilateral Basal Ganglia Calcification | Stroke
View all available purchase options and get full access to this article. Request permissions for this article. Tiantan Neuroimaging Center of Excellence, Beijing, China (Y.S.).…
Usefulness of Aortic Valve Calcification in Patients With Low-Flow Aortic Stenosis | Circulation: Cardiovascular Imaging
BACKGROUND: Aortic valve calcification (AVC) has been shown to be a powerful assessment of aortic stenosis (AS) severity and a predictor of adverse outcomes. However,…
New Treatment Option For Severe HCM in Children Shows Promise – American College of Cardiology
Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, may reduce morbidity and mortality in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the…
Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients
In dialysis-dependent patients, those on denosumab for fracture risk had a 36% higher MACE rate than those on bisphosphonates.
Argon Commences CLEAN-PE Study of Cleaner Pro Thrombectomy System – Cardiac Interventions Today
January 9, 2025—Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for…
ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH
The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling inhibitor.
Cardiology Grand Rounds Speaker Diversity
This cross-sectional study examines data for grand rounds lectures at 42 US institutions to gauge the representation of women among cardiology grand rounds speakers.
Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.